Belzutifan is a type of drug that blocks HIF-2α. It’s used to treat RCC linked to VHL. It works by cutting down on the signals that make tumors low on oxygen.
You can get the drug in 40 mg tablet form, with a film coating. The doc says you should take 120 mg of it every day. Each bottle holds 90 tablets.
Reviews
There are no reviews yet.